Multichannel
Connected HCP experiences: The holy grail of precision marketing
Still stuck in multichannel and too often serving up undifferentiated messaging, pharma has much to do to understand and serve individual HCPs
Multichannel
Wired for success in omnichannel
The mastery of omnichannel requires many parts of every pharma business to align and co-operate but perhaps one of the most important, but...
Multichannel
Connected HCP experiences: The holy grail of precision marketing
Pharma has a long way to go to achieve a truly tailored customer experience, down to the level of individual healthcare providers...
Latest
-
-
Multichannel
Wired for success in omnichannel
Marcomms has much to gain by nurturing a closer working relationship with IT colleagues -
Patients and Medical
Advocacy in hemophilia: Crafting a path that leaves no-one behind
Implementing an ethical and realistic global access strategy for hemophilia so that patients everywhere can receive treatment -
Multichannel
Getting ready for primetime in cell & gene therapy
As thousands of novel cell and gene therapies advance along the development pipeline, pressure mounts for scalable treatments -
Commercial
Building a commercial dream team for today’s pharma industry
The transformation in the way pharma and HCPs interact is leading pharma companies to reorganize and rethink the makeup and approach of its commercialization teams
Most Popular
Andrew Stone, (Mar 14, 2023)
Still stuck in multichannel and too often serving up undifferentiated messaging, pharma has much to do to understand and serve individual HCPs
Clare Jackson, (Feb 8, 2023)
Implementing an ethical and realistic global access strategy for hemophilia so that patients everywhere can receive treatment
Joseph Constance, (Mar 13, 2023)
Marcomms has much to gain by nurturing a closer working relationship with IT colleagues
Opinion
Jill Donahue, (Mar 16, 2023)
For Zena Sfeir, Aitia VP Marketing, a strong sense of purpose is key to making an impact and improving lives
Jill Donahue, (Sep 5, 2022)
For Ana Paula Carvalho, President of Western Europe Cluster, Pfizer, her purpose began amidst overcoming challenges.
Commercial
-
Building a commercial dream team for today’s pharma industry
The transformation in the way pharma and HCPs interact is leading pharma companies to reorganize and rethink the makeup and approach of its commercialization teams -
Omnichannel: How will pharma get there?
The journey from multichannel to omnichannel requires closer data co-ordination, an agile approach, new metrics and nimbler content management -
Becoming agile in experience measurement
The customer experience is pharma’s new competitive battleground – trust is its key metric, and the prizes will go to the nimble -
Paving the payment path for DTx
The digital therapeutics reimbursement process is maturing but complexity and risk remain to be managed -
The field force: Is small beautiful?
As big pharma ponders the right sizing of its post-pandemic field forces, can it learn from smaller, leaner industry peers about doing more with less?
Access and Evidence
-
RWE’s new dataset: Social media
Pharma is waking up to the potential of social media to enhance existing RWD sources and to offer altogether new insights in rare disease and beyond -
How automation is changing regulatory affairs
Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing -
An early peek at the FDA’s RWE ‘cookbook’
The FDA is developing guidelines that will help pharma accelerate its adoption of RWE, this is what the industry should know -
The future is bright for RWE in pharma approvals
The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task -
Payers and the ABCs of digital literacy
Convincing payers of the value of digital add-ons and of drug/device combinations requires pharma to demonstrate that patients and other stakeholders understand how to use them
Patients and Medical
-
Advocacy in hemophilia: Crafting a path that leaves no-one behind
Implementing an ethical and realistic global access strategy for hemophilia so that patients everywhere can receive treatment -
Digital Health: Letting human nature drive design
End users are increasingly important partners in developing digital health solutions, to the benefit of all -
Advancing health equity for the LGBTQIA+ community
Marginalised and with a range of unmet health needs, LGBTQIA+ patients are not getting the care they need. Pharma can help. -
Advocacy in Hemophilia: Building the Future by Design
Creating a visionary paradigm for the future of hemophilia and rare diseases that disrupts current thinking -
Bringing hope in hemophilia
By collaborating, gathering compelling global data and sharing knowledge hemophilia advocates are driving fairer and broader access to diagnosis and treatment
Latest Videos
Upcoming Events
View All EventsMarch 2023
-
Pharma USA 2023
Mar 28, 2023 - Mar 29, 2023
April 2023
-
Pharma Europe 2023
Apr 18, 2023 - Apr 20, 2023
May 2023
-
Digital Health USA 2023
May 16, 2023 - May 17, 2023
June 2023
-
Value Based Health USA 2023
Jun 5, 2023 - Jun 6, 2023
October 2023
-
Customer Engagement USA 2023
Oct 2, 2023 - Oct 3, 2023
-
Pharma & Patient USA 2023
Oct 2, 2023 - Oct 3, 2023
November 2023
-
Customer Engagement Europe 2023
Nov 9, 2023 - Nov 10, 2023